Phase II trial of single-agent temsirolimus (CCI-779) for relapsed mantle cell lymphoma.
Witzig TE; Geyer SM; Ghobrial I; Inwards DJ; Fonseca R; Kurtin P; Ansell SM; Luyun R; Flynn PJ; Morton RF; Dakhil SR; Gross H; Kaufmann SH; Journal Of Clinical Oncology: Official Journal Of The American Society Of Clinical Oncology, 2005, vol. 23, issue 23, p 5347, ISSN 0732183x. ISBN 0732183x.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef